In an effort to reach a potential $22 billion cash global settlement of opioid lawsuits, lawyers are clashing over a critical obstacle that hit the courts this week: who should get attorney fees, and how much?
The fight over fees reached a pinnacle this week after numerous states, cities and counties filed court papers opposing a proposal that any opioid settlement or judgment would require corporate defendants to holdback 7% for “common benefit fees” to compensate the lawyers in charge of the multidistrict litigation. Even the opioid defendants themselves—the primary distributors and manufacturers of the prescription painkillers named in the lawsuits—said the proposed holdback by the plaintiffs’ executive committee would “seriously jeopardize the global settlement.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
